{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:08:20Z","timestamp":1793880500881,"version":"4.7.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.semarthrit.2022.152151","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T02:02:02Z","timestamp":1670551322000},"page":"152151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Patient global assessment is elevated by up to 5 of 10 units in patients with inflammatory arthritis who screen positive for fibromyalgia (by FAST4) and\/or\u00a0depression (by MDS2) on a\u00a0single MDHAQ"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5708-5971","authenticated-orcid":false,"given":"Juan","family":"Schmukler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa M.","family":"Morla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Luta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Pincus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.semarthrit.2022.152151_bib0001","first-page":"579","article-title":"Development of a disease activity score based on judgment in clinical practice by rheumatologists","volume":"20","author":"van der Heijde","year":"1993","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152151_bib0002","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"5 Suppl 39","key":"10.1016\/j.semarthrit.2022.152151_bib0003","first-page":"S100","article-title":"The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis","volume":"23","author":"Aletaha","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2022.152151_bib0004","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3899\/jrheum.080182","article-title":"RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories","volume":"35","author":"Pincus","year":"2008","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.semarthrit.2022.152151_bib0005","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1136\/ard.2008.100826","article-title":"ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis","volume":"68","author":"van der Heijde","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152151_bib0006","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/ard.2009.122259","article-title":"Application of the DAREA\/DAPSA score for assessment of disease activity in psoriatic arthritis","volume":"69","author":"Schoels","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152151_bib0007","first-page":"47","article-title":"Relative efficiencies of the 7 rheumatoid arthritis Core Data Set measures to distinguish active from control treatments in 9 comparisons from clinical trials of 5 agents","volume":"32 Suppl 85","author":"Pincus","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152151_bib0008","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.rdc.2019.07.001","article-title":"Treat to target in rheumatology: a historical account on occasion of the 10th anniversary","volume":"45","author":"Smolen","year":"2019","journal-title":"Rheum Dis Clin North Am"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152151_bib0009","first-page":"1138","article-title":"Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or american college of rheumatology criteria for remission","volume":"30","author":"Sokka","year":"2003","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2022.152151_bib0010","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1002\/art.22193","article-title":"Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: comparison of patients according to their eligibility for major randomized clinical trials","volume":"54","author":"Zink","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152151_bib0011","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/rheumatology\/keq334","article-title":"Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis","volume":"50","author":"Radner","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.semarthrit.2022.152151_bib0012","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s10067-019-04574-6","article-title":"The effect of concomitant hand osteoarthritis on pain and disease activity in patients with rheumatoid arthritis","volume":"38","author":"Ruiz-Medrano","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2022.152151_bib0013","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1136\/annrheumdis-2020-218744","article-title":"Role of joint damage, malalignment and inflammation in articular tenderness in rheumatoid arthritis, psoriatic arthritis and osteoarthritis","volume":"80","author":"Gessl","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152151_bib0014","first-page":"1453","article-title":"Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis","volume":"57","author":"Duffield","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.semarthrit.2022.152151_bib0015","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/rheumatology\/kep170","article-title":"Depression in RA patients treated with anti-TNF is common and under-recognized in the rheumatology clinic","volume":"48","author":"Hider","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152151_bib0016","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3899\/jrheum.080897","article-title":"Outcome and predictor relationships in fibromyalgia and rheumatoid arthritis: evidence concerning the continuum versus discrete disorder hypothesis","volume":"36","author":"Wolfe","year":"2009","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.semarthrit.2022.152151_bib0017","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1093\/rheumatology\/ket169","article-title":"The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis","volume":"52","author":"Matcham","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152151_bib0018","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/ard.2009.123919","article-title":"Treating rheumatoid arthritis to target: recommendations of an international task force","volume":"69","author":"Smolen","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152151_bib0019","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/annrheumdis-2013-203419","article-title":"Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force","volume":"73","author":"Smolen","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152151_bib0020","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.rdc.2019.07.002","article-title":"Treat to target in psoriatic arthritis","volume":"45","author":"Zhang","year":"2019","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.semarthrit.2022.152151_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2021.07.005","article-title":"Patient perspective on remission in rheumatoid arthritis: validation of patient reported outcome instruments to measure absence of disease activity","author":"Rasch","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152151_bib0022","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/annrheumdis-2021-221653","article-title":"Re-examining remission definitions in rheumatoid arthritis: considering the 28-joint disease activity score, C-reactive protein level and patient global assessment","volume":"81","author":"Felson","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152151_bib0023","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.semarthrit.2020.03.022","article-title":"Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission","volume":"50","author":"Aletaha","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2022.152151_bib0024","article-title":"American college of rheumatology\/EULAR remission criteria for rheumatoid arthritis: 2022 Revision","author":"Studenic","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152151_bib0025","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3899\/jrheum.100594","article-title":"Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia","volume":"38","author":"Wolfe","year":"2011","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2022.152151_bib0026","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152151_bib0027","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152151_bib0028","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40674-021-00175-0","article-title":"A self-report multidimensional health assessment questionnaire (MDHAQ) for face-to-face or telemedicine encounters to assess clinical severity (RAPID3) and screen for fibromyalgia (FAST) and depression (DEP)","volume":"7","author":"Gibson","year":"2021","journal-title":"Curr Treatm Opt Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152151_bib0029","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3899\/jrheum.190277","article-title":"Fibromyalgia assessment screening tool: clues to fibromyalgia on a multidimensional health assessment questionnaire for routine care","volume":"47","author":"Gibson","year":"2020","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152151_bib0030","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/acr2.11053","article-title":"Fibromyalgia assessment screening tools (FAST) based on only multidimensional health assessment questionnaire (MDHAQ) scores as clues to fibromyalgia","volume":"1","author":"Schmukler","year":"2019","journal-title":"ACR Open Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152151_bib0031","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/acr.24467","article-title":"Multidimensional health assessment questionnaire as an effective tool to screen for depression in routine rheumatology care","volume":"73","author":"Morla","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152151_bib0032","first-page":"1432","article-title":"Further development of a physical function scale on a MDHAQ for standard care of patients with rheumatic diseases","volume":"32","author":"Pincus","year":"2005","journal-title":"J Rheumatol"},{"issue":"6 Suppl 47","key":"10.1016\/j.semarthrit.2022.152151_bib0033","first-page":"69","article-title":"Quantitative measurement of patient status in the regular care of patients with rheumatic diseases over 25 years as a continuous quality improvement activity, rather than traditional research","volume":"25","author":"Pincus","year":"2007","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152151_bib0034","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/art.1780380612","article-title":"A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity","volume":"38","author":"Stucki","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152151_bib0035","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/acr.21793","article-title":"Patient self-report RADAI (rheumatoid arthritis disease activity index) joint counts on an MDHAQ (multidimensional health assessment questionnaire) in usual care of consecutive patients with rheumatic diseases other than rheumatoid arthritis","volume":"65","author":"Castrejon","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2022.152151_bib0036","series-title":"The rheumatologist","article-title":"New applications of the MDHAQ: can remote use improve detection of adverse events due to high-risk medications?","author":"Schmukler","year":"2019"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152151_bib0037","first-page":"93","article-title":"The use of MDHAQ\/RAPID3 in different rheumatic diseases a review of the literature","volume":"75","author":"Castrejon","year":"2017","journal-title":"Bull Hosp Jt Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152151_bib0038","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/RHU.0b013e3182936b98","article-title":"MDHAQ\/RAPID3 to recognize improvement over 2 months in usual care of patients with osteoarthritis, systemic lupus erythematosus, spondyloarthropathy, and gout, as well as rheumatoid arthritis","volume":"19","author":"Castrejon","year":"2013","journal-title":"J Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152151_bib0039","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.rdc.2009.10.008","article-title":"RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care","volume":"35","author":"Pincus","year":"2009","journal-title":"Rheum Dis Clin North Am"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152151_bib0040","first-page":"178","article-title":"RheuMetric a physician checklist to record patient levels of inflammation, damage and distress as quantitative data rather than as narrative impressions","volume":"73","author":"Castrejon","year":"2015","journal-title":"Bull Hosp Jt Dis"},{"issue":"Suppl A","key":"10.1016\/j.semarthrit.2022.152151_bib0041","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0896-8411(92)90036-P","article-title":"The case for early intervention in rheumatoid arthritis","volume":"5","author":"Pincus","year":"1992","journal-title":"J Autoimmun"},{"key":"10.1016\/j.semarthrit.2022.152151_bib0042","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12891-016-1083-y","article-title":"Usefulness of the SF-36 health survey in screening for depressive and anxiety disorders in rheumatoid arthritis","volume":"17","author":"Matcham","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152151_bib0043","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s13075-016-1151-6","article-title":"Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature","volume":"18","author":"Nikiphorou","year":"2016","journal-title":"Arthritis research & therapy"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152151_bib0044","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/msc.1046","article-title":"Different wording of the Patient Global Visual Analogue Scale (PG-VAS) affects rheumatoid arthritis patients\u2019 scoring and the overall Disease Activity Score (DAS28): a cross-sectional study","volume":"11","author":"French","year":"2013","journal-title":"Musculoskeletal care"},{"issue":"12","key":"10.1016\/j.semarthrit.2022.152151_bib0045","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1136\/annrheumdis-2011-201142","article-title":"Patient\u2019s global assessment of disease activity and patient\u2019s assessment of general health for rheumatoid arthritis activity assessment: are they equivalent?","volume":"71","author":"Khan","year":"2012","journal-title":"Annals of the rheumatic diseases"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152151_bib46","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1136\/ard.2008.097345","article-title":"Test-retest reliability of disease activity core set measures and indices in rheumatoid arthritis","volume":"68","author":"Uhlig","year":"2009","journal-title":"Annals of the rheumatic diseases"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017222002025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017222002025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:11:56Z","timestamp":1758733916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017222002025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":46,"alternative-id":["S0049017222002025"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152151","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient global assessment is elevated by up to 5 of 10 units in patients with inflammatory arthritis who screen positive for fibromyalgia (by FAST4) and\/or\u00a0depression (by MDS2) on a\u00a0single MDHAQ","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152151","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152151"}}